期刊文献+

80岁以上老年急性白血病12例临床分析 被引量:7

Clinical Analysis of 12 Acute Leukemia Patients Aged over 80 Years
下载PDF
导出
摘要 本研究探讨80岁以上老年急性白血病的临床特点。对我院2000-2010年收治的12例80岁以上急性白血病患者进行回顾性分析,其中9例急性髓系白血病,3例急性淋巴细胞白血病,均合并有多种基础疾病,大部分患者一般情况较差,接受了个体化治疗方案的患者共10例。结果表明,2例患者获得完全缓解,其余患者未获得缓解。平均生存时间20±16周。AML患者平均生存时间为27±14周,明显长于国外报道。生存期最短的3例均为ALL患者。结论:本组高龄AML患者采取个体化治疗,生存期得到明显延长。而高龄老年ALL患者则预后很差,缺乏相对有效的治疗措施。 The objective of this study was to explore the clinical features of acute leukemia patients aged over 80 years.12 cases of acute leukemia patients aged over 80 years who were diagnosed from 2000 to 2010 years were analyzed retrospectively.9 caseas suffered from acute myelogenous leukemia and 3 cases were with acute lymphoblastic leukemia.All patients were with several complicated diseases and the general status was poor in most patients.10 cases received individualized treatments.The results showed that 2 patients achieved complete remission,but in other patients was not observed remission and the mean survival time was 20±16 weeks.In AML patients,the mean survival time was 27±14 weeks which was obviously longer than that in other reports.The survival time in 3 ALL patients was shortest.In conclusion,survival time was prolonged obviously in AML patients well advanced of age after individualized treatments,but prognosis of ALL in aged patients was very poor,for whom there is no relatively effective treatment.
出处 《中国实验血液学杂志》 CAS CSCD 2011年第1期139-142,共4页 Journal of Experimental Hematology
关键词 老年急性白血病 急性淋巴细胞白血病 急性髓系白血病 elderly acute leukemia acute lymphoblastic leukemia acute myelogenous leukemia
  • 相关文献

参考文献8

  • 1DeLima M, Ghaddar H, Pierce S, et al. Treatment of newly diagnosed acute myelogenous leukaemia in patients aged 80 years and above. Br J Haematol, 1996 ;93 ( 1 ) : 89 - 95. 被引量:1
  • 2Latagliata R, Alimena G, Carmosino I, et al. Conservative treatment for patients over 80 years with acute myelogenous leukemia. Am J Hematol, 2002 ;71 (4) :256 - 259. 被引量:1
  • 3Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD, National Cancer Institute, 2010. Available at http://seer, cancer, gov/csr/1975 - 2007/. 被引量:1
  • 4Taylor PR, Reid MM, Brown N, et al. Acute lymphoblastic leukemia in patients aged 60 years and over: a population based study of incidence and outcome. Blood, 1992 ; 80 (7) : 1813 - 1817. 被引量:1
  • 5Juliusson G, Antunovic P, Derolf A, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood, 2009; 113 ( 18 ) : 4179 -4187. 被引量:1
  • 6Kadia TM, Kashani FR, O'Brien SM, et al. Evaluation of efficacy and mortality in elderly patients (70 years or older) with acute myeloid leukemia treated with intensive chemotherapy. J Clin Oncol, 2010 ; 28 ( 15 s ) : abstr 6529. 被引量:1
  • 7Robak T, Szmigielska-Kaplon A, Wrzesiefi-Kus A, et al. acute lymphoblstic leukemia in elderly: the Polish Adult Leukemia group (PALG) experience. Ann Hematol, 2004 ; 83 ( 4 ) : 225 - 231. 被引量:1
  • 8Brandwein JM, Gupta V, Wells RA, et al. Treatment of elderly patients with acute lymphoblastc leukemia-Evidence for a benefit of imatinib in BCR-ABL positive patients. Leuk Res, 2005 ;29 (12) : 1381 - 1386. 被引量:1

同被引文献62

  • 1窦立萍,于力,徐周敏,靳海杰,赵瑜,李红华,王全顺,楼方定.血液系统疾病中LRP15基因启动子区甲基化状态的研究[J].军医进修学院学报,2006,27(5):341-343. 被引量:1
  • 2李睿,陈燕.老年急性白血病的临床特点及免疫学表型的研究[J].中国实验血液学杂志,2006,14(6):1221-1226. 被引量:8
  • 3刘春燕,付蓉,刘文会,程毓倩,宋文秀,杜丽娟,阮二宝,张丽彤,王晓明,梁勇,王国锦,瞿文,宋嘉,张荣莉,关晶,李丽娟,宋妍,高珊,刘惠,江汇涓,王珺,邹鹏,邵宗鸿.急性非淋巴细胞白血病预后及相关因素分析[J].中国实验血液学杂志,2007,15(6):1300-1304. 被引量:3
  • 4Cheson B D,Bennett J M,Kopecky K J. Revised recommendations of the International Working Group for Diagnosis,Standardization of Response Criteria,Treatment Outcomes,and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia[J].Journal of Clinical Oncology,2003,(24):4642-4649. 被引量:1
  • 5Slovak M L,Kopecky K J,Cassileth P A. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia:a Southwest Oncology Group/Eastern Cooperative Oncology Group Study[J].Blood,2000,(13):4075-4083. 被引量:1
  • 6Ferrara F,Palmieri S,Leoni F. Clinically useful prognostic factors in acute myeloid leukemia[J].Critical Reviews in Oncology/Hematology,2008,(03):181-193. 被引量:1
  • 7Avivi I. J M Rowe Prognostic factors in acute myeloid leukemia[J].Current Opinion in Hematology,2005,(01):62-67. 被引量:1
  • 8Haferlach T,Kern W,Schoch C. A new prognostic score for patients with acute myeloid leukemia based on cytogenetics and early blast clearance in trials of the German AML Cooperative Group[J].Haematologica,2004,(04):408-418. 被引量:1
  • 9Appelbaum F R,H Gundacker,D R Head. Age and acute myeloid leukemia[J].Blood,2006,(09):3481-3485.doi:10.1182/blood-2005-09-3724. 被引量:1
  • 10de Nully Brown P,Jurlander J,Pedersen-Bjergaard J. The prognostic significance of chromosomal analysis and immunophenotyping in 117 patients with de novo acute myeloid leukemia[J].Leukemia Research,1997,(10):985-995. 被引量:1

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部